You are here: Industry Insights > DRL

News List

Pharma cos foray into digital healthcare to bolster personalised care in India: GlobalData expresspharma
August 09, 2021
In the last three years, Abbott, Biocon, Cipla, Dr Reddy's Laboratories and Lupin have launched digital health initiatives.
DRDO launches anti-COVID drug 2-DG expresspharma
May 18, 2021
The first batch of DRDO-developed anti-COVID drug 2-DG (2-deoxy-D-glucose) has been launched to treat patients suffering from the deadly COVID-19. The medicine comes in powder form and can be taken with water.
DRL to sell neurology branded products to Upsher-Smith Laboratories expressbpd
June 14, 2019
Dr Reddy’s would sell its US and select territory rights for ZEMBRACE SYMTOUCH and TOSYMRATM, which are commercialized through its wholly-owned subsidiary, Promius Pharma
DRL recalls 2,770 bags of epilepsy injection in US expressbpd
February 22, 2019
The reason for recall is the pre-printed text on the primary infusion bag and the national drug code (NDC) incorrectly identifies the product as Levetiracetam in 0.75 per cent Sodium Chloride (1000 mg/100 mL)
DRL launches Chlorthalidone Tablets, USP in the US market expressbpd
November 29, 2018
The tablets are available in 25 mg tablets in the bottle-count sizes of 100 and 1000, and 50 mg tablets
DRL gets EIR from US FDA expressbpd
April 11, 2018
Dr Reddy’s Laboratories (DRL) has received establishment inspection report from the US health regulator for its Cuernavaca facility in Mexico.
Brexit Alliance calls for Brexit deal on medicines regulation pharmatimes
January 30, 2018
The Brexit Health Alliance is again warning that medicines supply in the UK is in danger of being disrupted if the issue of co-operative regulation is not addressed during Brexit negotiations.
DRL launches melphalan hydrochloride for injection in US market expressbpd
December 27, 2017
The injection is available in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride
DRL launches Clofarabine injection in US market expressbpd
November 15, 2017
Dr Reddy’s Laboratories (DRL) has launched Clofarabine injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the US market, approved by the US Food & Drug Administration (US FDA).
DRL launches generic Azacitidine for Injection in Canada expressbpd
November 06, 2017
Dr Reddy’s Laboratories (DRL) announced that generic Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection), is approved by Health Canada.

Previous page 1 2 Next page